Published in Am J Pathol on December 05, 2011
Elucidating the metabolic regulation of liver regeneration. Am J Pathol (2013) 1.01
Characterization of the regulation and function of zinc-dependent histone deacetylases during rodent liver regeneration. Hepatology (2013) 0.92
Postponing the Hypoglycemic Response to Partial Hepatectomy Delays Mouse Liver Regeneration. Am J Pathol (2016) 0.79
Identification of an epigenetic signature of early mouse liver regeneration that is disrupted by Zn-HDAC inhibition. Epigenetics (2014) 0.76
Regulation of skeletal muscle mass in mice by a new TGF-beta superfamily member. Nature (1997) 14.82
Elucidation of a universal size-control mechanism in Drosophila and mammals. Cell (2007) 13.04
Identification of ubiquitin ligases required for skeletal muscle atrophy. Science (2001) 12.98
Liver failure and defective hepatocyte regeneration in interleukin-6-deficient mice. Science (1996) 6.70
Liver regeneration. J Cell Physiol (2007) 6.69
Regulation of muscle mass by myostatin. Annu Rev Cell Dev Biol (2004) 4.69
The Hippo pathway regulates Wnt/beta-catenin signaling. Dev Cell (2010) 4.49
Initiation of liver growth by tumor necrosis factor: deficient liver regeneration in mice lacking type I tumor necrosis factor receptor. Proc Natl Acad Sci U S A (1997) 4.33
Mammalian Mst1 and Mst2 kinases play essential roles in organ size control and tumor suppression. Proc Natl Acad Sci U S A (2010) 4.17
Quantitative real-time RT-PCR data analysis: current concepts and the novel "gene expression's CT difference" formula. J Mol Med (Berl) (2006) 4.00
Liver regeneration after partial hepatectomy: critical analysis of mechanistic dilemmas. Am J Pathol (2009) 3.55
Suppression of body fat accumulation in myostatin-deficient mice. J Clin Invest (2002) 3.28
WNT/beta-catenin signaling in liver health and disease. Hepatology (2007) 3.26
CCAAT enhancer- binding protein beta is required for normal hepatocyte proliferation in mice after partial hepatectomy. J Clin Invest (1998) 2.74
Disruption of hepatic adipogenesis is associated with impaired liver regeneration in mice. Hepatology (2004) 2.62
Conditional deletion of beta-catenin reveals its role in liver growth and regeneration. Gastroenterology (2006) 2.54
Analysis of liver regeneration in mice lacking type 1 or type 2 tumor necrosis factor receptor: requirement for type 1 but not type 2 receptor. Hepatology (1998) 1.96
Gadd45beta is induced through a CAR-dependent, TNF-independent pathway in murine liver hyperplasia. Hepatology (2005) 1.82
Liver regeneration is impaired in lipodystrophic fatty liver dystrophy mice. Hepatology (2010) 1.64
Epidermal growth factor receptor: a novel target of the Wnt/beta-catenin pathway in liver. Gastroenterology (2005) 1.58
Liver regeneration versus direct hyperplasia. FASEB J (1996) 1.47
Liver-specific loss of beta-catenin results in delayed hepatocyte proliferation after partial hepatectomy. Hepatology (2007) 1.40
Transient expression of cyclin D1 is sufficient to promote hepatocyte replication and liver growth in vivo. Cancer Res (2001) 1.35
Liver-specific ablation of integrin-linked kinase in mice results in abnormal histology, enhanced cell proliferation, and hepatomegaly. Hepatology (2008) 1.31
Compensatory recovery of liver mass by Akt-mediated hepatocellular hypertrophy in liver-specific STAT3-deficient mice. J Hepatol (2005) 1.31
Loss-of-function mutation in myostatin reduces tumor necrosis factor alpha production and protects liver against obesity-induced insulin resistance. Diabetes (2009) 1.31
Evidence that host size determines liver size: studies in dogs receiving orthotopic liver transplants. Hepatology (1987) 1.30
Evidence that cyclin D1 mediates both growth and proliferation downstream of TOR in hepatocytes. J Biol Chem (2002) 1.29
The survival pathways phosphatidylinositol-3 kinase (PI3-K)/phosphoinositide-dependent protein kinase 1 (PDK1)/Akt modulate liver regeneration through hepatocyte size rather than proliferation. Hepatology (2009) 1.26
Rapid growth of an intact human liver transplanted into a recipient larger than the donor. Gastroenterology (1987) 1.24
Evidence for non-traditional activation of complement factor C3 during murine liver regeneration. Mol Immunol (2008) 1.19
A common set of immediate-early response genes in liver regeneration and hyperplasia. Hepatology (2003) 1.08
Probing Prometheus: fat fueling the fire? Hepatology (2004) 1.06
Akt-mediated liver growth promotes induction of cyclin E through a novel translational mechanism and a p21-mediated cell cycle arrest. J Biol Chem (2007) 1.02
Indomethacin increases liver damage in a murine model of liver injury from alpha-1-antitrypsin deficiency. Hepatology (2006) 1.00
Rosiglitazone inhibits mouse liver regeneration. FASEB J (2006) 1.00
p21 is required for dextrose-mediated inhibition of mouse liver regeneration. Hepatology (2009) 0.99
Excessive hepatomegaly of mice with hepatocyte-targeted elimination of integrin linked kinase following treatment with 1,4-bis [2-(3,5-dichaloropyridyloxy)] benzene. Hepatology (2011) 0.87
Serum alpha-NH-butyric acid may predict spontaneous survival in pediatric acute liver failure. Pediatr Transplant (2008) 0.86
Adipose to the rescue: peripheral fat fuels liver regeneration. Hepatology (2010) 0.79
Reduction of liver mass due to malnutrition in rats. Correlation with emaciation of animals and size of organs not inserted in the portal system. Sao Paulo Med J (1996) 0.76
Murine functional liver mass is reduced following partial small bowel resection. J Gastrointest Surg (2009) 0.76
Cholesterol oxidation products are sensitive and specific blood-based biomarkers for Niemann-Pick C1 disease. Sci Transl Med (2010) 3.42
Disruption of hepatic adipogenesis is associated with impaired liver regeneration in mice. Hepatology (2004) 2.62
Increased homocysteine in a patient diagnosed with Marfan syndrome. Clin Chem (2010) 2.02
Baseline Analysis of a Young α-1-Antitrypsin Deficiency Liver Disease Cohort Reveals Frequent Portal Hypertension. J Pediatr Gastroenterol Nutr (2015) 1.98
Clinical utility of the reticulocyte hemoglobin content in the diagnosis of iron deficiency. Blood (2002) 1.96
A sensitive and specific LC-MS/MS method for rapid diagnosis of Niemann-Pick C1 disease from human plasma. J Lipid Res (2011) 1.76
Equimolar ammonia interference in potassium measurement on the Osmetech OPTI Critical Care Analyzer. Clin Chem (2006) 1.72
Liver regeneration is impaired in lipodystrophic fatty liver dystrophy mice. Hepatology (2010) 1.64
Ketogenesis prevents diet-induced fatty liver injury and hyperglycemia. J Clin Invest (2014) 1.63
Plasma Dickkopf1 (DKK1) concentrations negatively associate with atherosclerotic calcified plaque in African-Americans with type 2 diabetes. J Clin Endocrinol Metab (2012) 1.52
Delayed hepatocellular mitotic progression and impaired liver regeneration in early growth response-1-deficient mice. J Biol Chem (2004) 1.40
Abnormal glutamate homeostasis and impaired synaptic plasticity and learning in a mouse model of tuberous sclerosis complex. Neurobiol Dis (2007) 1.37
Repetitive hypoglycemia in young rats impairs hippocampal long-term potentiation. Pediatr Res (2003) 1.24
Directed microtubule growth, +TIPs, and kinesin-2 are required for uniform microtubule polarity in dendrites. Curr Biol (2010) 1.24
Evidence for non-traditional activation of complement factor C3 during murine liver regeneration. Mol Immunol (2008) 1.19
Prevalence of HIV infection among inpatients and outpatients in Department of Veterans Affairs health care systems: implications for screening programs for HIV. Am J Public Health (2007) 1.10
Reticulocyte hemoglobin content. Am J Hematol (2008) 1.07
Characterization of the association of tissue factor pathway inhibitor with human placenta. Arterioscler Thromb Vasc Biol (2002) 1.06
Apoptotic changes in the cortex and hippocampus following minimal brain trauma in mice. Brain Res (2006) 1.06
Analysis of serum inflammatory mediators identifies unique dynamic networks associated with death and spontaneous survival in pediatric acute liver failure. PLoS One (2013) 1.04
Effects of phosphate binder therapy on vascular stiffness in early-stage chronic kidney disease. Am J Nephrol (2013) 1.03
Dyskerin ablation in mouse liver inhibits rRNA processing and cell division. Mol Cell Biol (2009) 1.01
Rosiglitazone inhibits mouse liver regeneration. FASEB J (2006) 1.00
p21 is required for dextrose-mediated inhibition of mouse liver regeneration. Hepatology (2009) 0.99
Characterization of the regulation and function of zinc-dependent histone deacetylases during rodent liver regeneration. Hepatology (2013) 0.92
Analysis of the role of hepatic PPARγ expression during mouse liver regeneration. Hepatology (2012) 0.91
Characteristics of hepatocellular carcinoma in a murine model of alpha-1-antitrypsin deficiency. Hepatol Res (2010) 0.91
Impact of premature birth and critical illness on neonatal range of plasma amino acid concentrations determined by LC-MS/MS. Mol Genet Metab (2011) 0.90
Single-dose ketamine administration induces apoptosis in neonatal mouse brain. J Basic Clin Physiol Pharmacol (2005) 0.89
Trimming the fat from liver regeneration. Hepatology (2005) 0.88
First-trimester prediction of preeclampsia using metabolomic biomarkers: a discovery phase study. Prenat Diagn (2011) 0.88
Serum alpha-NH-butyric acid may predict spontaneous survival in pediatric acute liver failure. Pediatr Transplant (2008) 0.86
Impact of peripheral ketolytic deficiency on hepatic ketogenesis and gluconeogenesis during the transition to birth. J Biol Chem (2013) 0.86
Protection from pancreatitis by the zymogen granule membrane protein integral membrane-associated protein-1. J Biol Chem (2002) 0.85
Cobalamin F disease detected by newborn screening and follow-up on a 14-year-old patient. Pediatrics (2011) 0.83
Sickle hemoglobin disturbs normal coupling among erythrocyte O2 content, glycolysis, and antioxidant capacity. Blood (2013) 0.82
Sclerostin is positively associated with bone mineral density in men and women and negatively associated with carotid calcified atherosclerotic plaque in men from the African American-Diabetes Heart Study. J Clin Endocrinol Metab (2013) 0.82
Left ventricular mass progression despite stable blood pressure and kidney function in stage 3 chronic kidney disease. Am J Nephrol (2014) 0.81
Cystic fibrosis-associated liver disease: when will the future be now? J Pediatr Gastroenterol Nutr (2012) 0.80
Prevalence and Significance of Autoantibodies in Children with Acute Liver Failure. J Pediatr Gastroenterol Nutr (2016) 0.78
Outcomes of Children With and Without Hepatic Encephalopathy From the Pediatric Acute Liver Failure Study Group. J Pediatr Gastroenterol Nutr (2016) 0.78
Nuclear and mitochondrial localization signals overlap within bovine herpesvirus 1 tegument protein VP22. J Biol Chem (2005) 0.78
Circulating intact parathyroid hormone is suppressed at 25-hydroxyvitamin D concentrations >25 nmol/L in children. J Pediatr Endocrinol Metab (2014) 0.78
The apical sorting signal for human GLUT9b resides in the N-terminus. Mol Cell Biochem (2013) 0.78
Pregnancy in an NTBC-treated patient with hereditary tyrosinemia type I. J Pediatr Gastroenterol Nutr (2015) 0.77
Analytic performance of immunoassays for drugs of abuse below established cutoff values. Clin Chem (2004) 0.77
Murine functional liver mass is reduced following partial small bowel resection. J Gastrointest Surg (2009) 0.76
Detection of surreptitious administration of analog insulin to an 8-week-old infant. Pediatrics (2010) 0.76
Identification of an epigenetic signature of early mouse liver regeneration that is disrupted by Zn-HDAC inhibition. Epigenetics (2014) 0.76
Validation of lamellar body counts using three hematology analyzers. Am J Clin Pathol (2010) 0.76
Beta-phenylpyruvate and glucose uptake in isolated mouse soleus muscle and cultured C2C12 muscle cells. J Cell Biochem (2003) 0.75
Sharpening the CALIPER: defining pre-analytic and biologic variability in children. Clin Biochem (2012) 0.75
Lack of efficacy of the combination of pamidronate and vitamin D on regression of prostate cancer in the Dunning rat model. J Environ Pathol Toxicol Oncol (2003) 0.75
Intraindividual variability of thyroid function tests in a pediatric population. Clin Chim Acta (2010) 0.75
All plasma products are not created equal: Characterizing differences between plasma products. J Trauma Acute Care Surg (2015) 0.75
What is your guess? Lactescent plasma in acute leukemia. Clin Chem (2011) 0.75
Early-onset hepatic fibrosis in lysinuric protein intolerance. J Pediatr Gastroenterol Nutr (2011) 0.75
Differentiation of amphetamine/methamphetamine and other cross-immunoreactive sympathomimetic amines in urine samples by serial dilution testing. Clin Chem (2006) 0.75